Jade E. Jones, MD, discusses the importance of identifying the most effective first-line treatment regimen for PD-L1–positive TNBC.
Jade E. Jones, MD
Advertisement
Jade E. Jones, MD, is a medical oncologist at Winship Cancer Institute and assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine.
Articles by Jade E. Jones, MD
Advertisement
Latest Updated Articles
Dr Jones on the Implications of Data from ASCENT-04 for First-Line PD-L1+ TNBC ManagementPublished: July 15th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5